Elm Street Ventures

ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale

Business Model:

Revenue: $8.9M

Employees: 2-10

Rankings

Detailed Elm Street Ventures Information

Geographic Data

Elm Street Ventures headquarters map

Address: 33 Whitney Avenue

City: New Haven

State: CT

Zip: 06510

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

ESVC principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale University and other research institutions in the region (from New York City through Southern New England). With experienced management and access to local, professionally managed venture capital, Elm Street Ventures can help scientists build significant technology companies from the seed and early stage. Our partners include successful serial entrepreneurs and experienced corporate managers, who may serve as the interim CEOs or operating chairmen of a number of the companies we form. While they expect to be co-founders of companies in some circumstances, ESVC are also interested in hearing from entrepreneurs, scientists, and engineers who have already formed or plan to form new ventures in the life sciences. Attractive markets, solid patent protection and freedom to operate, defensible market position, and a world class management team are elements ultimately critical for success.

Contact Phone:
+12034014201

Contact Email:

Announced Date Company Transaction Money Raised
6/2007 BioRelix Series A 25.8M
1/2020 EvolveImmune Therapeutics Venture Round 17.5M
12/2008 Retail Optimization Series B 1.2M
2/2019 Halda Therapeutics Series A 0
6/2019 Artizan Biosciences Series A 0
2/2008 Affomix Corporation Series A 0
1/2009 Iconic Therapeutics Venture Round 2.5M
10/2009 Kolltan Pharmaceuticals Series A 0
6/2018 Iconic Therapeutics Venture Round 0
3/2021 Artizan Biosciences Series A 0
1/2009 ShareGrove Seed Round -
3/2017 P2 Science Series B 0
3/2017 Saphlux Series A 5M
3/2021 Cybrexa Therapeutics Series B 25M
6/2015 SeeClickFix Venture Round 1.6M
1/2020 CellFE Seed 4.8M
5/2012 Accelerated Orthopedic Technologies Seed Round 150k
4/2014 P2 Science Series A 1M
9/2013 Arvinas Series A 15M
4/2010 Metagenomix Seed Round 700k
1/2020 P2 Science Series C 0
5/2013 P2 Science Seed Round 650k
12/2014 Device42 Seed Round 3.5M
9/2012 Desmos Venture Round -
3/2021 Cybrexa Therapeutics Series B 0
3/2021 Artizan Biosciences Series A 0
1/2020 P2 Science Series C 0
1/2020 CellFE Seed Round 0
1/2020 EvolveImmune Therapeutics Venture Round 0
6/2019 Artizan Biosciences Series A 0
2/2019 Halda Therapeutics Series A 0
6/2018 Iconic Therapeutics Venture Round 0
3/2017 Saphlux Series A 0
3/2017 P2 Science Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research